IFN-I can activate inflammatory pathways such as NF-kB and MAPK, leading to the overproduction of proinflammatory cytokines, causing an excessive inflammatory response (CRS) in COVID-19 [28]. This evidence concerns the gene NFKB1 and congenital rubella syndrome.